Drug Shortage Report for AURO-TELMISARTAN

Last updated on 2023-11-29 History
Report ID 99162
Drug Identification Number 02453568
Brand name AURO-TELMISARTAN
Common or Proper name Telmisartan
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-09-30
Estimated end date 2023-11-30
Actual end date 2023-11-28
Shortage status Resolved
Updated date 2023-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2023-11-29 English Compare
v27 2023-11-28 French Compare
v26 2023-11-28 English Compare
v25 2023-11-28 French Compare
v24 2023-11-28 English Compare
v23 2023-10-02 French Compare
v22 2023-10-02 English Compare
v21 2023-09-13 French Compare
v20 2023-09-13 English Compare
v19 2023-08-29 French Compare
v18 2023-08-29 English Compare
v17 2023-07-24 French Compare
v16 2023-07-24 English Compare
v15 2021-10-29 French Compare
v14 2021-10-29 English Compare
v13 2021-07-27 French Compare
v12 2021-07-27 English Compare
v11 2021-04-30 French Compare
v10 2021-04-30 English Compare
v9 2021-02-03 French Compare

Showing 1 to 20 of 28